We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.19B
AUM Growth
+$13.5M
Cap. Flow
-$51.8M
Cap. Flow %
-4.34%
Top 10 Hldgs %
40.61%
Holding
149
New
17
Increased
46
Reduced
52
Closed
7

Top Buys

Rank Stock Value
1
GD icon
General Dynamics
GD
+$20M
2
CI icon
Cigna
CI
+$10.4M
3
MA icon
Mastercard
MA
+$9.47M
4
QRVO icon
Qorvo
QRVO
+$9.04M
5
NVDA icon
NVIDIA
NVDA
+$8.41M

Sector Composition

Rank Sector Weight
1 Technology 41.59%
2 Healthcare 19.27%
3 Financials 13.2%
4 Communication Services 10.46%
5 Consumer Discretionary 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
76
AbbVie
ABBV
$470B
$2.4M 0.2%
14,823
+11,858
+400% +$1.82M
PRFT
77
DELISTED
Perficient Inc
PRFT
$2.38M 0.2%
34,148
+15,731
+85% +$1.08M
ATVI
78
DELISTED
Activision Blizzard
ATVI
$2.38M 0.2%
31,087
-98,140
-76% -$7.29M
SIMO icon
79
Silicon Motion
SIMO
$7.07B
$2.37M 0.2%
36,533
-2,736
-7% -$168K
MRNA icon
80
Moderna
MRNA
$21.6B
$2.35M 0.2%
13,081
+490
+4% +$80.1K
NDSN icon
81
Nordson
NDSN
$16.4B
$2.34M 0.2%
9,854
-1,500
-13% -$342K
JNJ icon
82
Johnson & Johnson
JNJ
$645B
$2.3M 0.19%
13,008
SYK icon
83
Stryker
SYK
$135B
$2.17M 0.18%
8,884
+300
+3% +$68.1K
ILMN icon
84
Illumina
ILMN
$28.9B
$2.13M 0.18%
10,811
-24,509
-69% -$5.08M
LLY icon
85
Eli Lilly
LLY
$1.08T
$2.1M 0.18%
+5,740
New +$2.04M
VRTX icon
86
Vertex Pharmaceuticals
VRTX
$124B
$2M 0.17%
6,928
+700
+11% +$213K
HUM icon
87
Humana
HUM
$43.7B
$1.91M 0.16%
3,730
+600
+19% +$315K
CALX icon
88
Calix
CALX
$2.26B
$1.8M 0.15%
26,293
+49
+0.2% +$3.29K
BIIB icon
89
Biogen
BIIB
$31.1B
$1.71M 0.14%
6,190
QDEL icon
90
QuidelOrtho
QDEL
$1.13B
$1.69M 0.14%
+19,774
New +$1.67M
SAIC icon
91
Saic
SAIC
$4.95B
$1.66M 0.14%
14,972
-693
-4% -$73K
UI icon
92
Ubiquiti
UI
$31.5B
$1.55M 0.13%
5,663
+501
+10% +$149K
CTRA
93
DELISTED
Coterra Energy
CTRA
$1.51M 0.13%
+61,541
New +$1.7M
FFIV icon
94
F5
FFIV
$22.3B
$1.51M 0.13%
10,525
LRCX icon
95
Lam Research
LRCX
$316B
$1.47M 0.12%
35,000
+7,150
+26% +$299K
ABG icon
96
Asbury Automotive
ABG
$4.67B
$1.43M 0.12%
7,980
+3,369
+73% +$563K
PCTY icon
97
Paylocity
PCTY
$7.87B
$1.4M 0.12%
7,220
EXEL icon
98
Exelixis
EXEL
$14B
$1.4M 0.12%
87,117
-12,226
-12% -$199K
MODV
99
DELISTED
ModivCare
MODV
$1.32M 0.11%
+14,747
New +$1.32M
HII icon
100
Huntington Ingalls Industries
HII
$11.3B
$1.21M 0.1%
+5,254
New +$1.24M

Similar funds

Oak Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Oak Associates held 149 positions worth $1.19B, up 1.1% from $1.18B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Oak Associates withdrew a net $51.8M in Q4 2022, closing 7 positions and reducing 52 holdings. Its most notable exit was Skyworks Solutions, an estimated $26.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oak Associates opened a new position in General Dynamics worth $20.3M.

  • Oak Associates's largest Q4 2022 buy was General Dynamics: 81,824 shares worth $20.3M.
  • Oak Associates added most to Cigna in Q4 2022, an estimated $10.4M increase.
  • Oak Associates's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $13.7M.
  • Oak Associates fully exited Skyworks Solutions in Q4 2022, selling an estimated $26.9M.
  • Oak Associates's ten largest holdings make up 41% of its $1.19B portfolio in Q4 2022.
  • Oak Associates opened 17 new positions and closed 7 in Q4 2022.
  • Oak Associates's portfolio value rose 1.1% quarter-over-quarter to $1.19B.

Based on Oak Associates's 13F filing for Q4 2022, filed 9 Feb 2023.